<DOC>
	<DOCNO>NCT00116103</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness tacrolimus inhalation aerosol subject persistent asthma .</brief_summary>
	<brief_title>A Study Safety Efficacy Tacrolimus Inhalation Aerosol Subjects With Persistent Asthma</brief_title>
	<detailed_description>The purpose randomize , double-blind , placebo-controlled , parallel-group , multi-center design trial determine safety efficacy tacrolimus inhalation aerosol subject persistent asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Diagnosis persistent asthma least 6 month Require use betaagonists least four time per week Diagnosis chronic obstructive pulmonary disease ( COPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Investigational , Therapies</keyword>
	<keyword>Asthma</keyword>
	<keyword>Antiasthmatics</keyword>
	<keyword>Antiasthmatic agent</keyword>
</DOC>